SEC Filings

Filing date	Form	Description	View
06/03/14	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-14-043506.pdf 0001104659-14-043506.rtf 0001104659-14-043506.xls
05/19/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-008766.pdf 0001179110-14-008766.rtf 0001179110-14-008766.xls
05/15/14	CT ORDER	CT ORDER	View HTML 9999999997-14-009843.pdf
05/15/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0000903423-14-000321.pdf 0000903423-14-000321.rtf 0000903423-14-000321.xls
05/14/14	CERTNAS	CERTNAS	View HTML 9999999997-14-009727.pdf 9999999997-14-009727.rtf
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008431.pdf 0001179110-14-008431.rtf 0001179110-14-008431.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008432.pdf 0001179110-14-008432.rtf 0001179110-14-008432.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008433.pdf 0001179110-14-008433.rtf 0001179110-14-008433.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008434.pdf 0001179110-14-008434.rtf 0001179110-14-008434.xls
05/14/14	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-14-008435.pdf 0001179110-14-008435.rtf 0001179110-14-008435.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools